EGFR and non-small cell lung carcinoma: This revealed that NAT10 knockdown resulted in the downregulation of multiple lipid metabolism-related genes, building on the finding that NAT10 knockdown increases the sensitivity of NSCLC cells to EGFR-TKI treatment by inhibiting cell proliferation and promoting apoptosis (Fig. 4A-B).